BGI Group has been at the forefront in the fight against COVID-19, from sequencing the 2019-nCoV virus genome to offering RT-PCR and sequencing-based detection solutions. BGI's RT-PCR Kit received FDA EUA on Mar 26 and ready for commercial distribution in the US market. This webinar will present details of the RT-PCR kit as well as BGI's integrated workflows from automated sample prep, viral RNA extraction to RT-PCR testing, as well as a mNGS test that have been deployed in China and over 60 countries.